RECORD // Company

Champions Oncology, Inc.

Formerly: CHAMPIONS BIOTECHNOLOGY, INC.; CHAMPIONS SPORTS INC

Built 2026-11-21T11:29:27Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
SEC EDGAR (1)
Matched by name only, not merged (4)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Champions Oncology · Ctgov · exact name match to 'CHAMPIONS ONCOLOGY, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • CHAMPIONS ONCOLOGY, INC · East licences · same registered legal name as 'CHAMPIONS ONCOLOGY, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CHAMPIONS ONCOLOGY, INC · Epa echo · same registered legal name as 'CHAMPIONS ONCOLOGY, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CHAMPIONS ONCOLOGY, INC. · USAspending · same registered legal name as 'CHAMPIONS ONCOLOGY, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare

5 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-07-31, filed 2026-09-11 · accession 0001628280-26-061519

ItemValuePeriodFormFiledAccessionReport
Revenue$15,232,0003 months ended 2026-07-3110-Q2026-09-110001628280-26-0615192026-11-21 11:29 UTCReport an error
Net income (loss)$-426,0003 months ended 2026-07-3110-Q2026-09-110001628280-26-0615192026-11-21 11:29 UTCReport an error
Cash and cash equivalents$4,358,000at 2026-07-3110-Q2026-09-110001628280-26-0615192026-11-21 11:29 UTCReport an error
Contract liabilities (total)$9,552,000at 2026-07-3110-Q2026-09-110001628280-26-0615192026-11-21 11:29 UTCReport an error
Contract liabilities, current$9,552,000at 2026-07-3110-Q2026-09-110001628280-26-0615192026-11-21 11:29 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0000771856
Ticker
CSBR
EIN
521401755
Record ID
sx:sec:0000771856

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

30 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-09SEC EDGAR company profile2026-11-21 11:29 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-09SEC EDGAR company profile2026-11-21 11:29 UTCReport an error
State of incorporationDE2026-11-09SEC EDGAR company profile2026-11-21 11:29 UTCReport an error
Fiscal year end (MMDD)04302026-11-09SEC EDGAR company profile2026-11-21 11:29 UTCReport an error
Business address855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 212052026-11-09SEC EDGAR company profile2026-11-21 11:29 UTCReport an error
ExchangesNasdaq2026-11-09SEC EDGAR company profile2026-11-21 11:29 UTCReport an error
Revenue (fiscal year ended 2026-04-30)$59,425,0002026-04-3010-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-21 11:29 UTCReport an error
Net income (loss) (fiscal year ended 2026-04-30)$-1,175,0002026-04-3010-K, XBRL NetIncomeLoss2026-11-21 11:29 UTCReport an error
Total assets (at 2026-04-30)$26,989,0002026-04-3010-K, XBRL Assets2026-11-21 11:29 UTCReport an error
Stockholders' equity (at 2026-04-30)$3,939,0002026-04-3010-K, XBRL StockholdersEquity2026-11-21 11:29 UTCReport an error
Cash and cash equivalents (at 2026-04-30)$4,872,0002026-04-3010-K, XBRL CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents2026-11-21 11:29 UTCReport an error
Operating cash flow (fiscal year ended 2026-04-30)$-4,472,0002026-04-3010-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 11:29 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2026-04-30)$564,0002026-04-3010-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 11:29 UTCReport an error
Operating lease liabilities (at 2026-04-30)$4,512,0002026-04-3010-K, XBRL OperatingLeaseLiability2026-11-21 11:29 UTCReport an error
Form D total offering amount (D filed 2015-03-25)$14,000,0002015-03-25D2026-11-21 11:29 UTCReport an error
Form D total amount sold (D filed 2015-03-25)$14,000,0002015-03-25D2026-11-21 11:29 UTCReport an error
Form D industry groupBiotechnology2015-03-25D2026-11-21 11:29 UTCReport an error
Form D revenue range$5,000,001 - $25,000,0002015-03-25D2026-11-21 11:29 UTCReport an error
Form D date of first sale2015-03-132015-03-25D2026-11-21 11:29 UTCReport an error
8-K Item 5.07, Submission of Matters to a Vote of Security Holders (filed 2026-10-16)On October 14, 2026, Champions Oncology, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results were as follows: 1. Election of Directors. The seven director nominees named in the Company's 2026 proxy statement were elected to serve for a one-year term expiring at the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified, based upon the following votes: Director Nominee Votes For Votes Withheld Broker Non-Vote Robert Brainin 7,904,120 338,790 461,706 Ronnie Morris, M.D. 7,883,105 359,805 461,706 Joel Ackerman…2026-10-16SEC EDGAR 8-K 0001628280-26-066087 (text as filed, excerpt)2026-11-21 11:29 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-09-10)On September 10, 2026, Champions Oncology, Inc. (the “Company”) issued a press release regarding the Company’s unaudited financial results for its first quarter ended July 31, 2026. A copy of the Company’s press release is attached hereto as Exhibit 99.1. The information contained under Item 2.02 in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.2026-09-10SEC EDGAR 8-K 0001628280-26-061383 (text as filed, excerpt)2026-11-21 11:29 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-07-27)On July 27, 2026, Champions Oncology, Inc. (the “Company”) issued a press release regarding the Company’s audited financial results for its fiscal year ended April 30, 2026. A copy of the Company’s press release is attached hereto as Exhibit 99.1. The information contained under Item 2.02 in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.2026-07-27SEC EDGAR 8-K 0001628280-26-049822 (text as filed, excerpt)2026-11-21 11:29 UTCReport an error
Employer name (as filed)Champions Oncology, Inc.2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:29 UTCReport an error
Certified LCAs12026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:29 UTCReport an error
Certified LCAs later withdrawn02026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:29 UTCReport an error
Total worker positions on certified LCAs12026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:29 UTCReport an error
Top job titles (title, LCA count)Preclinical Project Manager, Surgical Services (1)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:29 UTCReport an error
Wage offered, annualized (n, min, median, max)median $60,403 (range $60,403-$60,403, 1 filings)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:29 UTCReport an error
Worksite statesMD2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:29 UTCReport an error
Plan (pension, plan no. 001)CHAMPIONS ONCOLOGY 401(K) PLAN: 442 participants, assets $7,825,6512025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:29 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.